TY  - JOUR
AU  - Zugazagoitia, J
AU  - Ramos, I
AU  - Trigo, J M
AU  - Palka, M
AU  - Gómez-Rueda, A
AU  - Jantus-Lewintre, E
AU  - Camps, C
AU  - Isla, D
AU  - Iranzo, P
AU  - Ponce-Aix, S
AU  - García-Campelo, R
AU  - Provencio, M
AU  - Franco, F
AU  - Bernabé, R
AU  - Juan-Vidal, O
AU  - Felip, E
AU  - de Castro, J
AU  - Sanchez-Torres, J M
AU  - Faul, I
AU  - Lanman, R B
AU  - Garrido, P
AU  - Paz-Ares, L
PY  - 2019
DO  - 10.1093/annonc/mdy512
UR  - https://hdl.handle.net/10668/27526
T2  - Annals of oncology : official journal of the European Society for Medical Oncology
AB  - Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We have analyzed the clinical utility of next-generation sequencing (NGS) of cell-free circulating...
LA  - en
KW  - actionable genomic alterations
KW  - co-occurring genomic alterations
KW  - ctDNA
KW  - digital next-generation sequencing
KW  - insufficient tissue
KW  - lung adenocarcinoma
KW  - Adenocarcinoma of Lung
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - Circulating Tumor DNA
KW  - DNA, Neoplasm
KW  - Female
KW  - Follow-Up Studies
KW  - Genome, Human
KW  - Genomics
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Precision Medicine
KW  - Prognosis
KW  - Prospective Studies
KW  - Proto-Oncogene Proteins
KW  - Survival Rate
TI  - Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
TY  - research article
VL  - 30
ER  -